Senti Biosciences
SNTI
SNTI
25 hedge funds and large institutions have $7.56M invested in Senti Biosciences in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.13% less ownership
Funds ownership: 2.7% → 2.57% (-0.13%)
Holders
25
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$102K | |
| 2 | +$94.9K | |
| 3 | +$28.8K | |
| 4 |
Two Sigma Investments
New York
|
+$18.9K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$14.3K |
Top Sellers
| 1 | -$1.34M | |
| 2 | -$102K | |
| 3 | -$47.1K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$17.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$83 |